Location: Cambridge, MA
CIK: 0001400240 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.54B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GENB | GENERATE BIOMEDICINES INC | 62,673,117 | $1.057B | 68.7% | — | — | COM SHS | 370920100 |
| MRNA | MODERNA INC | 4,632,149 | $324M | 21.1% | — | — | COM | 60770K107 |
| SANA | SANA BIOTECHNOLOGY INC | 25,001,856 | $87.26M | 5.7% | — | — | COM | 799566104 |
| FHTX | FOGHORN THERAPEUTICS INC | 12,674,120 | $61.85M | 4.0% | — | — | COM | 344174107 |
| MCRB | SERES THERAPEUTICS INC | 1,155,850 | $9.12M | 0.6% | — | — | COM NEW | 81750R201 |